Ad
related to: pancreatic cancer rare- Safety And Tolerability
Access Safety And Adverse
Reaction Information On The Site.
- Mechanism Of Action
Learn About An FDA-Approved
Treatment Option Here.
- Efficacy And Study Design
Learn More About The Study Design
And View Efficacy Data Here.
- Dosing
Find Dosing Information At The
Official Physician Site.
- Safety And Tolerability
Search results
Results from the WOW.Com Content Network
Pancreatic cancer rarely occurs before the age of 40, and more than half of cases of pancreatic adenocarcinoma occur in those over 70. [2] Risk factors for pancreatic cancer include tobacco smoking, obesity, diabetes, and certain rare genetic conditions. [2] About 25% of cases are linked to smoking, [3] and 5–10% are linked to inherited genes ...
VIPoma, producing excessive vasoactive intestinal peptide, which may cause profound chronic watery diarrhea and resultant dehydration, hypokalemia, and achlorhydria (WDHA or pancreatic cholera syndrome) somatostatinoma: these rare tumors are associated with elevated blood glucose levels, achlorhydria, cholelithiasis, and diarrhea [16]
Acinar cell carcinoma of the pancreas, also acinar cell carcinoma, is a rare malignant exocrine tumour of the pancreas. It represents 5% of all exocrine tumours of the pancreas, making it the second most common type of pancreatic cancer. [1] It is abbreviated ACC. It typically has a guarded prognosis.
Related: FDA Approves New Treatment for Metastatic Pancreatic Cancer The 24 hours before the surgery were probably the most nerve-wracking for me. The night before, I was full of a lot of emotions ...
The 45-year-old television personality was diagnosed with a rare type of pancreatic cancer, a pancreatic neuroendocrine tumor, in January and had it removed the following month.
Relative incidences of various pancreatic neoplasms, with pancreatoblastoma annotated at center right. [1] Pancreatoblastoma is a rare type of pancreatic cancer. [2] It occurs mainly in childhood [3] and has a relatively good prognosis.
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.
A pancreatic tumor is an abnormal growth in the pancreas. [1] In adults, almost 90% are pancreatic cancer and a few are benign. [1] Pancreatic tumors are rare in children. [1] Classification is based on cellular differentiation (ductal, acinar, neuroendocrine, other) and gross appearance (intraductal, cystic, solid). [1]
Ad
related to: pancreatic cancer rare